Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Legislation Seeks Medicare Recognition of Genetic Counselors to Expand Access to Care

November 26th 2018, 8:53pm

Article

To receive payment for counseling and increase access to services, a new bill has been introduced so that genetic counselors receive payment for counseling Medicare beneficiaries.

Giving Teeth to Oral Care

November 17th 2018, 9:01pm

Article

Certain cancer treatments can affect the mouth, so dental health should be a lifelong commitment.

FDA Grants Lynparza Priority Review for Frontline Maintenance in Ovarian Cancer

November 12th 2018, 6:50pm

Article

The FDA has granted a priority review designation to a supplemental new drug application (sNDA) for Lynparza (olaparib) tablets for use as a maintenance therapy in patients with newly-diagnosed, BRCA-positive advanced ovarian cancer who achieved a complete or partial response to standard frontline platinum-based chemotherapy.

Starting a Conversation

November 11th 2018, 7:00pm

Article

Families with certain genetic mutations face many complex and personal choices, including how and when to share such information with their children. Mom's Genes is here to help.

When Your Partner Has Cancer, It May Feel Like You Do Too

November 2nd 2018, 5:30pm

Article

Here are some tips on coping with the disease that seems to affect us all.

CURE's Top 5 Stories: October 2018

November 1st 2018, 4:00pm

Article

Here are the top 5 CURE stories for October 2018.

Maintenance Lynparza Improves PFS for Ovarian Cancer

October 30th 2018, 10:09pm

Article

The PARP inhibitor Lynparza (olaparib) significantly improved progression-free survival (PFS) as frontline maintenance therapy for women with BRCA-positive advanced ovarian cancer, according to findings from the randomized phase 3 SOLO-1 trial presented at the 2018 ESMO Congress.

Cobie Smulders: Not on My Watch

October 25th 2018, 4:50pm

Podcast

Actress partners with TESARO to launch national movement to help empower the ovarian cancer community

Joining Forces Against Hereditary Risk for Breast and Ovarian Cancer

October 24th 2018, 4:21pm

Article

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

Discussing Hereditary Cancer Risk With Children

October 22nd 2018, 10:55pm

Article

Although there is never the perfect time to have a risk-related discussion with a child, one clinical psychologist explains ways in which parents can approach the difficult topic.